This document provides guidance on preparing for and responding to FDA inspections and audits. It advises that companies should always be prepared for an audit and not do last minute preparations. During an audit, companies should be prepared to provide documentation, address any previous issues, and communicate openly with inspectors. Following an audit, companies must submit corrective actions to address any issues found and should evaluate their entire quality system to determine the root causes of problems and prevent reoccurrences.